SAN DIEGO--(BUSINESS WIRE)--Quidel Corporation (NASDAQ: QDEL) (“Quidel”), a leading provider of rapid diagnostic testing solutions, cellular-based virology assays and molecular diagnostic systems, ...

SAN DIEGO--(BUSINESS WIRE)--With Lyme disease season in full-swing across the United States and as the public continues spending increasing time outdoors during the COVID-19 pandemic, Quidel’s ...

Partnership includes donation of Quidel’s QuickVue® At-Home OTC COVID-19 Tests to Chicago Blackhawks Foundation community partners Recipients of the first Quidel donation include SOS Villages, ...

The makers of at-home rapid Covid tests are scrambling to meet soaring demand as consumers prepare for holiday gatherings and tests are suddenly in short supply amid another coronavirus surge.

A new study raises significant doubts about whether at-home rapid antigen tests can detect the Omicron variant before infected people can transmit the virus to others. The study looks at 30 people ...

San Diego’s Quidel Corp. boosted its fourth quarter sales forecast on Thursday after the omicron and delta variants sparked increased demand for its rapid at-home COVID-19 tests. The company, which ...

Some antigen tests, including the rapid COVID-19 test made by the Abbott BinaxNOW and Quidel QuickVue brands, may fail to detect if you have omicron, according to new data released this week. In ...